Report Detail

Request for Sample of this report

Chemical & Material Global Recombinant Streptavidin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4721472
    • |
  • 16 July, 2026
    • |
  • Global
    • |
  • 99 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Recombinant Streptavidin market size was valued at US$ 98 million in 2025 and is forecast to a readjusted size of US$ 157 million by 2032 with a CAGR of 6.9% during review period.
Recombinant streptavidin refers to streptavidin obtained via recombinant expression, including its core fragments, mutants, tagged, or conjugated versions, used to form high-affinity complexes with biotinylated molecules. The product’s gross margin is approximately 63%.
Demand for recombinant streptavidin primarily comes from in vitro diagnostics, antibody/protein detection, cell analysis, nucleic acid capture, and biosensing applications. Recombinant streptavidin is not a finished kit but a key raw material in the biotin–streptavidin system. Its advantages include high affinity, good batch-to-batch consistency, and ease of engineering, resulting in stable demand in research reagents and diagnostic raw materials.
On the supply side, basic expression and purification processes are mature, and prices for standard untagged products are becoming transparent. Price differentiation is mainly driven by purity, endotoxin control, aggregate management, GMP or diagnostic-grade validation, and functional versions such as fluorescent, enzyme-labeled, affinity-tagged, single-use, or reversible-binding forms. International life science companies hold brand and distribution advantages, while Chinese suppliers are rapidly improving in standard products and small-batch customizations.
Future growth will come more from high-value differentiation than from volume expansion of ordinary proteins. Domestic substitution for IVD raw materials, automated testing platforms, SPR/sensor chip development, protein interaction, and nucleic acid capture workflows will generate incremental demand. Meanwhile, downstream customers increasingly value low background, low endotoxin, stability, and traceable batches, driving the market toward diagnostic-grade, GMP-grade, and engineered mutant recombinant streptavidin.
This report is a detailed and comprehensive analysis for global Recombinant Streptavidin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Recombinant Streptavidin market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Recombinant Streptavidin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Recombinant Streptavidin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Recombinant Streptavidin market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Streptavidin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Streptavidin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Abcam, ACROBiosystems, Sino Biological, Aladdin, ProSpec, Jena Bioscience, MedChemExpress, Creative BioMart, GenScript, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Recombinant Streptavidin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Recombinant Streptavidin Protein
Core Streptavidin Protein
Tagged Streptavidin Protein
Mutant Streptavidin Protein
Conjugated Streptavidin Protein
GMP-Grade Streptavidin Protein
Market segment by Modification Type
Unmodified
Affinity-Tagged
Fluorescent-Labeled
Enzyme-Labeled
Reactive-Activated
Other
Market segment by Binding Mode
Tetrameric High-Affinity
Monovalent Binding
Reversible Binding
Reduced Biotin Affinity
Control Protein
Other
Market segment by Application
IVD Reagent Manufacturing
Immunoassay Reagent Manufacturing
Flow Cytometry Reagent Manufacturing
Nucleic Acid Capture Workflow
Protein Purification Media Production
Sensor Chip Functionalization
Research Reagent Packaging
Major players covered
Thermo Fisher Scientific
Abcam
ACROBiosystems
Sino Biological
Aladdin
ProSpec
Jena Bioscience
MedChemExpress
Creative BioMart
GenScript
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Streptavidin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Streptavidin, with price, sales quantity, revenue, and global market share of Recombinant Streptavidin from 2021 to 2026.
Chapter 3, the Recombinant Streptavidin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Streptavidin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Recombinant Streptavidin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Streptavidin.
Chapter 14 and 15, to describe Recombinant Streptavidin sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Recombinant Streptavidin Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Recombinant Streptavidin Protein
    • 1.3.3 Core Streptavidin Protein
    • 1.3.4 Tagged Streptavidin Protein
    • 1.3.5 Mutant Streptavidin Protein
    • 1.3.6 Conjugated Streptavidin Protein
    • 1.3.7 GMP-Grade Streptavidin Protein
  • 1.4 Market Analysis by Modification Type
    • 1.4.1 Overview: Global Recombinant Streptavidin Consumption Value by Modification Type: 2021 Versus 2025 Versus 2032
    • 1.4.2 Unmodified
    • 1.4.3 Affinity-Tagged
    • 1.4.4 Fluorescent-Labeled
    • 1.4.5 Enzyme-Labeled
    • 1.4.6 Reactive-Activated
    • 1.4.7 Other
  • 1.5 Market Analysis by Binding Mode
    • 1.5.1 Overview: Global Recombinant Streptavidin Consumption Value by Binding Mode: 2021 Versus 2025 Versus 2032
    • 1.5.2 Tetrameric High-Affinity
    • 1.5.3 Monovalent Binding
    • 1.5.4 Reversible Binding
    • 1.5.5 Reduced Biotin Affinity
    • 1.5.6 Control Protein
    • 1.5.7 Other
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Recombinant Streptavidin Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 IVD Reagent Manufacturing
    • 1.6.3 Immunoassay Reagent Manufacturing
    • 1.6.4 Flow Cytometry Reagent Manufacturing
    • 1.6.5 Nucleic Acid Capture Workflow
    • 1.6.6 Protein Purification Media Production
    • 1.6.7 Sensor Chip Functionalization
    • 1.6.8 Research Reagent Packaging
  • 1.7 Global Recombinant Streptavidin Market Size & Forecast
    • 1.7.1 Global Recombinant Streptavidin Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Recombinant Streptavidin Sales Quantity (2021-2032)
    • 1.7.3 Global Recombinant Streptavidin Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Recombinant Streptavidin Product and Services
    • 2.1.4 Thermo Fisher Scientific Recombinant Streptavidin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.2 Abcam
    • 2.2.1 Abcam Details
    • 2.2.2 Abcam Major Business
    • 2.2.3 Abcam Recombinant Streptavidin Product and Services
    • 2.2.4 Abcam Recombinant Streptavidin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abcam Recent Developments/Updates
  • 2.3 ACROBiosystems
    • 2.3.1 ACROBiosystems Details
    • 2.3.2 ACROBiosystems Major Business
    • 2.3.3 ACROBiosystems Recombinant Streptavidin Product and Services
    • 2.3.4 ACROBiosystems Recombinant Streptavidin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 ACROBiosystems Recent Developments/Updates
  • 2.4 Sino Biological
    • 2.4.1 Sino Biological Details
    • 2.4.2 Sino Biological Major Business
    • 2.4.3 Sino Biological Recombinant Streptavidin Product and Services
    • 2.4.4 Sino Biological Recombinant Streptavidin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Sino Biological Recent Developments/Updates
  • 2.5 Aladdin
    • 2.5.1 Aladdin Details
    • 2.5.2 Aladdin Major Business
    • 2.5.3 Aladdin Recombinant Streptavidin Product and Services
    • 2.5.4 Aladdin Recombinant Streptavidin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Aladdin Recent Developments/Updates
  • 2.6 ProSpec
    • 2.6.1 ProSpec Details
    • 2.6.2 ProSpec Major Business
    • 2.6.3 ProSpec Recombinant Streptavidin Product and Services
    • 2.6.4 ProSpec Recombinant Streptavidin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 ProSpec Recent Developments/Updates
  • 2.7 Jena Bioscience
    • 2.7.1 Jena Bioscience Details
    • 2.7.2 Jena Bioscience Major Business
    • 2.7.3 Jena Bioscience Recombinant Streptavidin Product and Services
    • 2.7.4 Jena Bioscience Recombinant Streptavidin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Jena Bioscience Recent Developments/Updates
  • 2.8 MedChemExpress
    • 2.8.1 MedChemExpress Details
    • 2.8.2 MedChemExpress Major Business
    • 2.8.3 MedChemExpress Recombinant Streptavidin Product and Services
    • 2.8.4 MedChemExpress Recombinant Streptavidin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 MedChemExpress Recent Developments/Updates
  • 2.9 Creative BioMart
    • 2.9.1 Creative BioMart Details
    • 2.9.2 Creative BioMart Major Business
    • 2.9.3 Creative BioMart Recombinant Streptavidin Product and Services
    • 2.9.4 Creative BioMart Recombinant Streptavidin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Creative BioMart Recent Developments/Updates
  • 2.10 GenScript
    • 2.10.1 GenScript Details
    • 2.10.2 GenScript Major Business
    • 2.10.3 GenScript Recombinant Streptavidin Product and Services
    • 2.10.4 GenScript Recombinant Streptavidin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 GenScript Recent Developments/Updates

3 Competitive Environment: Recombinant Streptavidin by Manufacturer

  • 3.1 Global Recombinant Streptavidin Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Recombinant Streptavidin Revenue by Manufacturer (2021-2026)
  • 3.3 Global Recombinant Streptavidin Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Recombinant Streptavidin by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Recombinant Streptavidin Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Recombinant Streptavidin Manufacturer Market Share in 2025
  • 3.5 Recombinant Streptavidin Market: Overall Company Footprint Analysis
    • 3.5.1 Recombinant Streptavidin Market: Region Footprint
    • 3.5.2 Recombinant Streptavidin Market: Company Product Type Footprint
    • 3.5.3 Recombinant Streptavidin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Recombinant Streptavidin Market Size by Region
    • 4.1.1 Global Recombinant Streptavidin Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Recombinant Streptavidin Consumption Value by Region (2021-2032)
    • 4.1.3 Global Recombinant Streptavidin Average Price by Region (2021-2032)
  • 4.2 North America Recombinant Streptavidin Consumption Value (2021-2032)
  • 4.3 Europe Recombinant Streptavidin Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Recombinant Streptavidin Consumption Value (2021-2032)
  • 4.5 South America Recombinant Streptavidin Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Recombinant Streptavidin Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Recombinant Streptavidin Sales Quantity by Type (2021-2032)
  • 5.2 Global Recombinant Streptavidin Consumption Value by Type (2021-2032)
  • 5.3 Global Recombinant Streptavidin Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Recombinant Streptavidin Sales Quantity by Application (2021-2032)
  • 6.2 Global Recombinant Streptavidin Consumption Value by Application (2021-2032)
  • 6.3 Global Recombinant Streptavidin Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Recombinant Streptavidin Sales Quantity by Type (2021-2032)
  • 7.2 North America Recombinant Streptavidin Sales Quantity by Application (2021-2032)
  • 7.3 North America Recombinant Streptavidin Market Size by Country
    • 7.3.1 North America Recombinant Streptavidin Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Recombinant Streptavidin Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Recombinant Streptavidin Sales Quantity by Type (2021-2032)
  • 8.2 Europe Recombinant Streptavidin Sales Quantity by Application (2021-2032)
  • 8.3 Europe Recombinant Streptavidin Market Size by Country
    • 8.3.1 Europe Recombinant Streptavidin Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Recombinant Streptavidin Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Recombinant Streptavidin Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Recombinant Streptavidin Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Recombinant Streptavidin Market Size by Region
    • 9.3.1 Asia-Pacific Recombinant Streptavidin Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Recombinant Streptavidin Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Recombinant Streptavidin Sales Quantity by Type (2021-2032)
  • 10.2 South America Recombinant Streptavidin Sales Quantity by Application (2021-2032)
  • 10.3 South America Recombinant Streptavidin Market Size by Country
    • 10.3.1 South America Recombinant Streptavidin Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Recombinant Streptavidin Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Recombinant Streptavidin Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Recombinant Streptavidin Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Recombinant Streptavidin Market Size by Country
    • 11.3.1 Middle East & Africa Recombinant Streptavidin Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Recombinant Streptavidin Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Recombinant Streptavidin Market Drivers
  • 12.2 Recombinant Streptavidin Market Restraints
  • 12.3 Recombinant Streptavidin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Recombinant Streptavidin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Recombinant Streptavidin
  • 13.3 Recombinant Streptavidin Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Recombinant Streptavidin Typical Distributors
  • 14.3 Recombinant Streptavidin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Recombinant Streptavidin. Industry analysis & Market Report on Recombinant Streptavidin is a syndicated market report, published as Global Recombinant Streptavidin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Recombinant Streptavidin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo